clinical trials glp 1 GLP1 agonists: current and future landscape of for patients with metabolic dysfunction GLP-1 and Addiction: Clinical Trials

Cost, Insurance Driving Move to Compounded Drugs Compounded GLP-1 medications are not approved by the FDA, and the agency issued a warning in June calling them potentially risky for patients. This hasnt stopped patients from switching to the unapproved drugs, and 35% of patients who took compounded GLP-1s left from a name brand drug, according to Gallup

Additionally, patients with a BMI of 27 or higher who have at least one weight-related conditionsuch as type 2 diabetes, hypertension, or elevated cholesterolmay also qualify for treatment

Ordering from an unverified source carries several risks: Counterfeit Product: You may receive a pen that contains no active medication or, worse, a different substance

GLP-1s vs Other Diabetes and Weight Loss Drugs How They Compare with Insulin Insulin works fast but can cause weight gain and low blood sugar

Hannon, T

Indigestion (upset stomach)